ITabMed Ltd.
PrivateLast Round
Series A
Dec 1, 2021
Total Funding Raised
$20M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ITabMed Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in December 2021.
ITabMed Ltd. is a biotechnology company that focuses on the discovery and development of immunotherapy products to treat cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ITabMed Ltd. Comparables
Compare ITabMed Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Excalipoint Therapeutics | 84% | |
| Nanjing Leads Biolabs Co Ltd | 79% | |
| Merck & Co., Inc. | 76% |
For institutional investors. Book with your work email.
ITabMed Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
ITabMed Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Binhai Venture Capital | Series A |
| Bencao Capital | Series A |
| Yonjin Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 70% MoM.
- Dec 1, 2021
$20M round led by Yonjin Capital and Bencao Capital.
For institutional investors. Book with your work email.
ITabMed Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ITabMed Ltd.'s valuation, stock price, and market status.
Is ITabMed Ltd. a public or private company?
ITabMed Ltd. is a private company.
What is the current stock price of ITabMed Ltd.?
ITabMed Ltd. is a private company, so its shares have no public market price. Caplight tracks ITabMed Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ITabMed Ltd. worth (valuation)?
Valuation information for ITabMed Ltd. is not publicly available.
Can I buy ITabMed Ltd. stock?
ITabMed Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ITabMed Ltd.'s last funding round?
ITabMed Ltd.'s most recent funding round was Series A on December 1, 2021.
Who are the main investors in ITabMed Ltd.?
Key investors in ITabMed Ltd. include Bencao Capital, Yonjin Capital.
Will ITabMed Ltd. IPO soon?
No public IPO plans have been announced for ITabMed Ltd..
How can I track ITabMed Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in ITabMed Ltd.'s shares on secondary markets.